LeMaitre Vascular, Inc.
LMAT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $2 | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 13.6% | 19.7% | 4.7% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 68.6% | 65.7% | 64.9% | 65.7% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 30.4% | 25.3% | 22.8% | 29.8% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 20% | 15.6% | 12.8% | 17.4% |
| EPS Diluted | 1.93 | 1.34 | 0.93 | 1.25 |
| % Growth | 44% | 44.1% | -25.6% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |